Sequential low-dose CT thorax scans to determine invasive pulmonary fungal infection incidence after allogeneic hematopoietic cell transplantation
- PMID: 36460795
- PMCID: PMC9889523
- DOI: 10.1007/s00277-022-05062-9
Sequential low-dose CT thorax scans to determine invasive pulmonary fungal infection incidence after allogeneic hematopoietic cell transplantation
Abstract
Invasive fungal disease (IFD) during neutropenia goes along with a high mortality for patients after allogeneic hematopoietic cell transplantation (alloHCT). Low-dose computed tomography (CT) thorax shows good sensitivity for the diagnosis of IFD with low radiation exposure. The aim of our study was to evaluate sequential CT thorax scans at two time points as a new reliable method to detect IFD during neutropenia after alloHCT. We performed a retrospective single-center observational study in 265/354 screened patients admitted for alloHCT from June 2015 to August 2019. All were examined by a low-dose CT thorax scan at admission (CT t0) and after stable neutrophil recovery (CT t1) to determine the incidences of IFD. Furthermore, antifungal prophylaxis medications were recorded and cohorts were analyzed for statistical differences in IFD incidence using the sequential CT scans. In addition, IFD cases were classified according to EORTC 2008. At CT t0 in 9.6% of the patients, an IFD was detected and antifungal therapy initiated. The cumulative incidence of IFD in CT t1 in our department was 14%. The use of Aspergillus-effective prophylaxis through voriconazole or posaconazole decreased CT thorax t1 suggesting IFD is statistically significant compared to prophylaxis with fluconazole (5.6% asp-azol group vs 16.3% fluconazole group, p = 0.048). In 86%, CT t1 was negative for IFD. Low-dose sequential CT thorax scans are a valuable tool to detect pulmonary IFDs and guide antifungal prophylaxis and therapies. Furthermore, a negative CT t1 scan shows a benefit by allowing discontinuation of antifungal medication sparing patients from drug interactions and side effects.
Keywords: Allogeneic hematopoietic stem cell transplantation; Fungal infection; Incidence of fungal infection; Infectious diseases; Low-dose CT scans; Oncology; Prophylaxis of fungal infection.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no conflict of interest.
Similar articles
-
Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.Biol Blood Marrow Transplant. 2015 Jun;21(6):1117-26. doi: 10.1016/j.bbmt.2015.03.018. Epub 2015 Mar 31. Biol Blood Marrow Transplant. 2015. PMID: 25840339
-
Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.Front Cell Infect Microbiol. 2022 Jan 7;11:805514. doi: 10.3389/fcimb.2021.805514. eCollection 2021. Front Cell Infect Microbiol. 2022. PMID: 35071052 Free PMC article.
-
Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis.Bone Marrow Transplant. 2015 Nov;50(11):1465-72. doi: 10.1038/bmt.2015.181. Epub 2015 Aug 17. Bone Marrow Transplant. 2015. PMID: 26281032
-
Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects.J Antimicrob Chemother. 2013 Nov;68 Suppl 3:iii5-16. doi: 10.1093/jac/dkt389. J Antimicrob Chemother. 2013. PMID: 24155144
-
Development and validation of a risk model for identification of non-neutropenic, critically ill adult patients at high risk of invasive Candida infection: the Fungal Infection Risk Evaluation (FIRE) Study.Health Technol Assess. 2013 Feb;17(3):1-156. doi: 10.3310/hta17030. Health Technol Assess. 2013. PMID: 23369845 Free PMC article. Review.
References
-
- Morgan J, Wannemuehler KA, Marr KA, Hadley S, Kontoyiannis DP, Walsh TJ. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol. Januar. 2005;43(s1):49–58. - PubMed
-
- Martino R, Subira M, Rovira M, Solano C, Vazquez L, Sanz GF. Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients. Br J Haematol. Februar. 2002;116(2):475–82. - PubMed
-
- Ortega M, Rovira M, Almela M, Marco F, de la Bellacasa JP, Martínez JA. Bacterial and fungal bloodstream isolates from 796 hematopoietic stem cell transplant recipients between 1991 and 2000. Ann Hematol. Januar. 2005;84(1):40–6. - PubMed
-
- McCoy D, DePestel DD, Carver PL. Primary Antifungal Prophylaxis in Adult Hematopoietic Stem Cell Transplant Recipients: Current Therapeutic Concepts. Pharmacother. 2009;29(11):1306–1325. - PubMed
-
- Maertens J, Theunissen K, Verhoef G, Verschakelen J, Lagrou K, Verbeken E. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis Off Publ Infect Dis Soc Am 1. 2005;41(9):1242–50. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical